TY  - JOUR
AU  - Álvarez Prats, Alejandro
AU  - Hernández Perera, Octavio
AU  - Díaz Herrera, Pilar
AU  - Ucero Herrería, Álvaro Conrado
AU  - Anabitarte Prieto, Aránzazu
AU  - Losada Cabrera, Antonio
AU  - Ortiz, Alberto
AU  - Rodríguez Pérez, José C.
PY  - 2012
DO  - 10.1093/ndt/gfr671
SN  - 0931-0509
UR  - https://hdl.handle.net/20.500.14352/116735
T2  - Nephrology Dialysis Transplantation
AB  - BackgroundAngiotensin receptor 1 blockers (ARB) are standard nephroprotective drugs in chronic kidney disease. There is less evidence for a nephroprotective effect of HMG-CoA reductase inhibitors (statins) and much less is known about potential...
LA  - eng
M2  - 2720
PB  - Oxford Academics
KW  - Inflammation
KW  - Angiotensin
KW  - Kidney injury
TI  - Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy
TY  - journal article
VL  - 27
ER  -